All lobbying filings
BIOMERIEUX
BIOMERIEUX filed a Q1 report for BIOMERIEUX on April 20, 2026.
Lobbying for BIOMERIEUX · Medical diagnostics
Filing · LD-2 quarterly report
Q1 report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 20, 2026
Expenses
$190,000
What this organization spent lobbying with its own staff.
Reported using the LDA's own definitions (method A): the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
Utah
Government bodies contacted
2
Lobbying activity
4
Discussions regarding tariff proposals
Discussions regarding Veterans Affairs Appropriations Discussions regarding Indian Health Services Appropriations
Issues regarding womens health Equitable Community Access to Pharmacists Services Act
Discussions regarding PASTEUR Act, the RESULTS Act, CLIA Modernization, and antimicrobial resistance.